COL10A1 and neoplasm: Within the ECM, aberrant expression of collagen type X (COL10A1) in TNBC may activate the PI3K/AKT pathway, stimulating tumor-associated angiogenesis, and promoting TNBC growth and lung metastasis.445,446 Therefore, the downregulation of COL10A1 represents a potential therapeutic strategy.